Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1100920200410050339
Korean Journal of Family Medicine
2020 Volume.41 No. 5 p.339 ~ p.345
Anti-fracture Efficacy of Monthly Risedronate Compared with That of Weekly Risedronate in Postmenopausal Korean Women with Osteoporosis: A Nationwide Cohort Study
Cho Yong-Ho

Bae Kyung-Hyun
Lee Dong-Ryul
Lee Jung-Un
Abstract
Background: Intermittent dosing regimens for oral risedronate (once-monthly and once-weekly) were developed for patient convenience. While several studies have reported the anti-fracture efficacy of weekly dosing, few have assessed monthly dosing. The lower efficacy of monthly dosing has been previously suggested. The aim of this study was to compare the anti-fracture efficacy of monthly and weekly dosing.

Methods: We obtained information from the Korea National Health Insurance Service database from 2012 to 2017 of Korean women of ¡Ã50 years of age who used weekly or monthly risedronate. We compared the time of occurrence of the first osteoporotic fracture after the first prescription of risedronate. Using a Cox proportional model, we assessed incidence rate ratios (IRRs) with 95% confidence intervals (CIs) for fractures at any site, and the hip, vertebral, and non-vertebral sites between both regimens. Propensity score weighting was used to balance the treatment groups.

Results: The study populations were distributed according to dosing frequency (monthly, 27,329; weekly, 47,652). There was no significant difference in the incidence rate of new fractures in any site (IRR, 1.008; 95% CI,0.963?1.055; P=0.737), hip (IRR, 0.999; 95% CI, 0.769?1.298; P=0.996), vertebral (IRR, 0.962; 95% CI, 0.890?1.040; P=0.330), or non-vertebral (1.022; 95% CI, 0.968?1.078; P=0.439) sites between monthly and weekly risedronate.

Conclusion: The anti-fracture efficacy at any site and the examined individual sites was similar for the monthly and weekly risedronate regimens. Large-scale randomized controlled trials are required for confirmation.
KEYWORD
Bisphosphonate, Risedronic Acid, Osteoporosis, Fracture
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø